Limited treatment options and access to care often challenge patients with Friedreich’s ataxia. So, on Sept. 17, the ...
Editor’s note: This is an automatically generated transcript, which has been slightly edited for clarity. Please notify [email protected] if there are concerns regarding accuracy of the transcription.
WASHINGTON (7News) — Bill Nye, one of the nation's most popular scientists is headed to Capitol Hill to bring awareness to the rare neurological disease Ataxia. The dedicated scientist is teaming up ...
The agency will consider a submission that includes pooled data from ongoing studies, a decision analysts viewed as a notable ...
Lexeo Therapeutics, Inc. has received Breakthrough Therapy designation from the FDA for its treatment LX2006, which shows promising interim clinical data in improving cardiac and neurologic measures ...
Quince Therapeutics, Inc. (Nasdaq: QNCX), a late-stage biotechnology company dedicated to unlocking the power of a patient’s ...
PLANO, Texas--(BUSINESS WIRE)-- Reata Pharmaceuticals, Inc. (Nasdaq: RETA) (“Reata,” the “Company,” “our,” “us,” or “we”), a biopharmaceutical ...
Researchers at Ruhr University Bochum, Germany, identified a receptor that plays a crucial role in stress-induced motor ...
GRAND RAPIDS, Mich. — Twenty years ago, Frederick Pepper, at 60 years old, knew something was wrong. After a misdiagnosis for vertigo, a doctor found what was causing Pepper's unbalance. "That doctor ...
Daniel Fraser, 36, says his diagnosis has had a devastating impact on his family after doctors told him he has Friedreich's ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback